Last reviewed · How we verify
Topical IBU twice daily
Topical IBU twice daily is a NSAID Small molecule drug developed by Pfizer. It is currently in Phase 3 development for Relief of pain and inflammation associated with minor sprains, strains, and bruises.
Topical IBU works by reducing pain and inflammation at the site of application.
Topical IBU works by reducing pain and inflammation at the site of application. Used for Relief of pain and inflammation associated with minor sprains, strains, and bruises.
At a glance
| Generic name | Topical IBU twice daily |
|---|---|
| Sponsor | Pfizer |
| Drug class | NSAID |
| Modality | Small molecule |
| Therapeutic area | Pain Management |
| Phase | Phase 3 |
Mechanism of action
It does this by inhibiting the production of prostaglandins, which are hormone-like substances that cause pain and inflammation. Topical IBU is a nonsteroidal anti-inflammatory drug (NSAID) that is applied directly to the skin to provide localized relief from pain and inflammation.
Approved indications
- Relief of pain and inflammation associated with minor sprains, strains, and bruises
Common side effects
- Skin irritation
Key clinical trials
- Topical Ibuprofen for Delayed Onset Mulscle Soreness (PHASE3)
- 5% Topical Ibuprofen (IBU) for Ankle Sprain (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Topical IBU twice daily CI brief — competitive landscape report
- Topical IBU twice daily updates RSS · CI watch RSS
- Pfizer portfolio CI
Frequently asked questions about Topical IBU twice daily
What is Topical IBU twice daily?
How does Topical IBU twice daily work?
What is Topical IBU twice daily used for?
Who makes Topical IBU twice daily?
What drug class is Topical IBU twice daily in?
What development phase is Topical IBU twice daily in?
What are the side effects of Topical IBU twice daily?
Related
- Drug class: All NSAID drugs
- Manufacturer: Pfizer — full pipeline
- Therapeutic area: All drugs in Pain Management
- Indication: Drugs for Relief of pain and inflammation associated with minor sprains, strains, and bruises
- Compare: Topical IBU twice daily vs similar drugs
- Pricing: Topical IBU twice daily cost, discount & access